Sanofi (SNY) will acquire U.S. vaccine maker Dynavax Technologies (DVAX) for approximately $2.2 billion (1.9 billion euros), the French pharmaceutical company announced Wednesday.
Shares in French drugmaker Sanofi dropped more than 9% on Thursday following disappointing late-stage trial results for its experimental inflammatory disease drug amlitelimab.
24 Dec 2025-16:12
17 May 2021-22:12
